healthNewsغير مصنف

US insurers dragging feet on covering new drugs, Novartis says

BASEL (Reuters) – Getting U.S. government and commercial insurers to cover new medicines can now take longer than in Europe, Swiss drugmaker Novartis said on Wednesday, blaming U.S. delays for weaker than expected sales of a key heart failure treatment.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى